Evidence of microvascular dysfunction in heart failure with preserved ejection fraction
- PMID: 26567228
- PMCID: PMC4866903
- DOI: 10.1136/heartjnl-2015-308403
Evidence of microvascular dysfunction in heart failure with preserved ejection fraction
Abstract
Objective: While vascular dysfunction is well defined in patients with heart failure (HF) with reduced ejection fraction (HFrEF), disease-related alterations in the peripheral vasculature of patients with HF with preserved ejection fraction (HFpEF) are not well characterised. Thus, we sought to test the hypothesis that patients with HFpEF would demonstrate reduced vascular function, at the conduit artery and microvascular levels, compared with controls.
Methods: We examined conduit artery function via brachial artery flow-mediated dilation (FMD) and microvascular function via reactive hyperaemia (RH) following 5 min of ischaemia in 24 patients with Class II-IV HFpEF and 24 healthy controls matched for age, sex and brachial artery diameter.
Results: FMD was reduced in patients with HFpEF compared with controls (HFpEF: 3.1±0.7%;
Controls: 5.1±0.5%, p=0.03). However, shear rate at time of peak brachial artery dilation was lower in patients with HFpEF compared with controls (HFpEF: 42 070±4018/s;
Controls: 69 018±9509/s, p=0.01), and when brachial artery FMD was normalised for the shear stimulus, cumulative area-under-the-curve (AUC) at peak dilation, the between-group differences were eliminated (HFpEF: 0.11±0.03%/AUC;
Controls: 0.09±0.01%/AUC, p=0.58). RH, assessed as AUC, was lower in patients with HFpEF (HFpEF: 454±35 mL;
Controls: 660±63 mL, p<0.01).
Conclusions: Collectively, these data suggest that maladaptations at the microvascular level contribute to the pathophysiology of HFpEF, while conduit artery vascular function is not diminished beyond that which occurs with healthy aging.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Figures



Comment in
-
Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.Heart. 2016 Feb 15;102(4):257-9. doi: 10.1136/heartjnl-2015-308852. Heart. 2016. PMID: 27655221 No abstract available.
References
-
- Bhatia R, Tu J, Lee D, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260–269. - PubMed
-
- Bursi F, Weston S, Redfield M, et al. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209–2216. - PubMed
-
- Owan T, Hodge D, Herges R, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–259. - PubMed
-
- Fischer D, Rossa S, Landmesser U, et al. Endothelial dysfunction in patients with chronic heart failure is independently associated with increased incidence of hospitalization, cardiac transplantation, or death. European heart journal. 2005;26:65–69. - PubMed
-
- Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. Journal of the American College of Cardiology. 1992;19:918–925. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous